# Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

> **NCT00489515** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 115 (actual)

## Conditions studied

- Colorectal Cancer
- Gallbladder Cancer
- Gastric Cancer
- Pancreatic Cancer
- Small Intestine Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00489515
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** 2009-06
- **Final completion:** 2010-08
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489515, "Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00489515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*